Main Page

From My wiki
Jump to: navigation, search

[78] K. Hayashi, S. Wakino, K. Homma, N. Sugano, T. Saruta, "Pathophysiological significance of Ttype Ca2+ channels: function of T-type Ca2+ channels in renal microcirculation" J. Pharmacol Sci. vol. 99, no. three, pp. 221-227, Nov. 2005. [79] K. Hayashi, S. Wakino, N. Sugano, Y. Ozawa, K. Homma, T. Saruta, "Ca2+ channel subtypes and pharmacology inside the kidney" Circ. Res. vol. 100, no. 3, pp. 342-353, Feb. 2007. [80] C.B. Poulsen, R.H. Al-Mashhadi, L.L. Cribbs, O. Sk t, P.B. Hansen, "T-type voltage-gated calcium channels regulate the tone of mouse efferent arterioles" Kidney Int. vol. 79, no. 4, pp. 443-451, Feb. 2011. [81] M.G. Feng, M. Li, L.G. Navar, "T-type calcium channels in the regulation of afferent and efferent arterioles in rats" Am. J. Physiol. Renal. Physiol. vol. 286, no. 2, pp. F331-F337, Feb. 2004. [82] Y. Ozawa, K. Hayashi, T. Nagahama, K. Fujiwara, T. Saruta, "Effect of T-type selective calcium antagonist on renal microcirculation: research in the isolated perfused hydronephrotic kidney" Hypertension vol. 38, no. 3, pp. 343-7, Sep. 2001. 1940-0640-8-15 [83] Y. Abe Y, T. Komori, K. Miura, T. Takada, M. Imanishi, T. Okahara, K. Yamamoto, "Effects from the calcium antagonist nicardipine on renal function and renin release in dogs" J. Cardiovasc. Pharmacol. vol. five, no. two, pp. 254?59, Mar.Apr. 1983. [84] J.R. Dietz, J.O. Davis, R.H. Freeman, D. Villarreal, S.F. Echtenkamp, "Effects of intrarenal infusion of calcium entry blockers in anesthetized dogs" Hypertension. vol five, no. 4, pp. 482?88, Jul.-Aug. 1983. [85] J. Heller, V. Horacek, "The impact of two unique calcium antagonists around the glomerular haemodynamics in dogs" Pflugers Arch. vol. 415, no. six, pp. 751?55, Mar. 1990. [86] M. Roy, G.P. Guthrie, F.P. Holladay, T.A. Kotchen, "Effects of verapamil on renin and aldosterone in the dog and rat" Am. J. Physiol. vol. 245, no. 4, pp. E410 416, Oct. 1983. [87] B.M. Brenner, E.V. Lawler, H.S. Mackenzie, "The hyperfiltration theory: a paradigm shift in nephrology" Kidney Int. vol. 49, no. six, pp. 1774-1777, Jun. 1996. [88] K. Hayashi, K. Homma, S. Wakino, H. Tokuyama, N. Sugano, T. Saruta, H. Itoh, "T-type Ca channel blockade as a determinant of kidney protection" Keio J. Med. vol. 59, no. three, pp. 84-95, 2010. [89] A. Derwa, P. Peeters, R. Vanholder, "Calcium channel blockers inside the prevention of end stage renal disease: a review" Acta Clin. Belg. vol. 59, no. 1, pp. 44-56, Jan-Feb. 2004. [90] Fujiwara K, Kanno Y, Hayashi K, Takenaka T, Saruta T., Renal protective effects of efonidipine in partially nephrectomized spontaneously hypertensive rats. Clin. Exp. Hypertens. vol. 20, no. three, pp. 295-312, Apr. 1998.[91] T. Ishimitsu, T. Kameda, A. Akashiba, T. Takahashi, S. Ohta, M. Yoshii, J. Minami, H. Ono, A. Numabe, H. Matsuoka, "Efonidipine reduces proteinuria and plasma aldosterone in sufferers with chronic glomerulonephritis" Hypertens. Res. vol. 30, no. 7, pp. 621-626, Jul. 2007. [92] M. Kawabata, T. Ogawa, W.H. Han, T. Takabatake, "Renal effects of efonidipine hydrochloride, a new calcium antagonist, in spontaneously hypertensive rats with glomerular injury" Clin. Exp. Pharmacol.